This inventor holds 1 USPTO granted patent. Top assignee: Merck Patent Gesellschaft. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Norbert Meenen: Innovator in Cartilage Implant Technology
Introduction
Norbert Meenen is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of biomedical engineering, particularly in the development of cartilage implants. His innovative approach focuses on culturing chondrocytes under specific conditions to enhance the quality and functionality of cartilage tissue.
Latest Patents
Norbert Meenen holds a patent for a process titled "Culturing encapsulated chondrocytes under reduced oxygen partial pressure to produce cartilage implants." This patent outlines a method for producing human cartilage implants from chondrocytes cultured in vitro. The process aims to replicate the original biochemical composition and biomechanical properties of cartilage as closely as possible. The method incorporates up to 20% volume of human serum as a medium addition. Chondrocytes can be maintained in monolayer culture until the 12th passage, allowing for re-differentiation and subsequent stimulation to form three-dimensional cartilage tissue.
Career Highlights
Norbert Meenen is associated with Merck Patent Gesellschaft, where he applies his expertise in tissue engineering and regenerative medicine. His work has been instrumental in advancing the field of cartilage repair and regeneration.
Collaborations
Norbert has collaborated with notable colleagues, including Brigitte Jeschke and Jörg Meyer. Their combined efforts have contributed to the development of innovative solutions in the realm of cartilage tissue engineering.
Conclusion
Norbert Meenen's work in the field of cartilage implants showcases his dedication to advancing medical technology. His innovative patent reflects a significant step forward in the production of functional cartilage tissue, which has the potential to improve patient outcomes in regenerative medicine.